{
    "organizations": [],
    "uuid": "84c7787e8775c9fdd43707cd48a02189a93a4cb0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amphastar-pharmaceuticals-q1-gaap/brief-amphastar-pharmaceuticals-q1-gaap-loss-per-share-0-16-idUSASC0A14G",
    "ord_in_thread": 0,
    "title": "BRIEF-Amphastar Pharmaceuticals Q1 GAAP Loss Per Share $0.16",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Updated 10 minutes ago BRIEF-Amphastar Pharmaceuticals Q1 GAAP Loss Per Share $0.16 Amphastar Pharmaceuticals Inc:\n* AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 * Q1 GAAP LOSS PER SHARE $0.16\n* Q1 REVENUE $58.4 MILLION VERSUS I/B/E/S VIEW $60.8 MILLION\n* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.05\n* Q1 EARNINGS PER SHARE VIEW $0.08 â€” THOMSON REUTERS I/B/E/S ",
    "published": "2018-05-09T23:16:00.000+03:00",
    "crawled": "2018-05-09T23:30:49.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "q1",
        "gaap",
        "loss",
        "per",
        "share",
        "amphastar",
        "pharmaceutical",
        "inc",
        "amphastar",
        "pharmaceutical",
        "report",
        "financial",
        "result",
        "three",
        "month",
        "ended",
        "march",
        "q1",
        "gaap",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "adjusted",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters"
    ]
}